Perceive Bio
South San Francisco, United States · $93.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- perceivebio.com
- Total Funding
- $93.0M
- Last Round
- $78.0M Series BJan 2026
- Rounds
- 2
About
Gene therapy biotech advancing treatments for ophthalmology conditions including macular degeneration and glaucoma.
Summary
Perceive Bio is a Biotech company based in South San Francisco, United States. It has raised $93.0M in total across 2 rounds, most recently a $78.0M Series B round in Jan 2026. Investors include Johnson & Johnson Innovation, Deerfield Management and Retinal Degeneration Fund.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...